The Department of Medical Ethics and Health Policy and the Abramson Cancer Center’s Cancer Control Program are pleased to announce two upcoming talks by Jonathan Jackson, PhD. Dr. Jackson is an Assistant Professor of Neurology & Psychiatry, and Executive Director of the Community, Access, Recruitment, & Engagement (CARE) Research Center at Massachusetts General Hospital and Harvard Medical School.
Monday, June 6, 12PM - 1PM
Dr. Jackson's lecture is titled, "Belmont’s Third Pillar: Towards Justice in Clinical Research." This talk is part of the Research Ethics and Policy Series (REPS) Department of Medical Ethics & Health Policy. It will be held at the Biomedical Research Building - BRB 252 (421 Curie Blvd).
Tuesday, June 7, 12PM - 1PM
The ACC Cancer Control Program presents "The Challenge of Quantifiable Research Representation." It also will be held at the Biomedical Research Building – BRB 252 (421 Curie Blvd).
Events are free, open to the public, and hybrid. To-go lunches are provided.
Please register HERE.
Find more information on the event HERE.
More about Dr. Jackson:
Jonathan Jackson, PhD, is the executive director of the Community Access, Recruitment, and Engagement (CARE) Research Center at Massachusetts General Hospital and is an Assistant Professor of Neurology at Harvard Medical School. CARE investigates the impact of diversity and inclusion on the quality of human subjects research and leverages deep community entrenchment to build trust and overcome barriers to clinical trial participation. Jonathan’s research focuses on inequities in clinical settings that affect underserved populations, and he has received generous funding for this work from the Michael J Fox Foundation for Parkinson’s Research, Massachusetts General Hospital and the National Institutes of Health, including a prestigious NIH Pioneer Award to advance this work. Dr. Jackson, who received his doctoral degree in Psychological and Brain Sciences in 2014, also conducts research as a cognitive neuroscientist investigating the early detection of Alzheimer’s disease, particularly in the absence of overt memory problems. He has become a well-known representative to underserved communities and dozens of affiliated organizations, especially regarding participation in clinical research. Dr. Jackson serves in an advisory capacity for several organizations focused on equity in clinical research, and has written guidance for local, statewide, national, and federal organizations on research access, engagement, and recruitment.
Follow on Twitter: